-
Nanotech Helps Reduce Cancer Drug Side Effects
Researchers at MIT in Cambridge, Massachusetts and Brigham and Women’s Hospital in Boston have shown that they can use nanotechnology to deliver the cancer drug cisplatin much more effectively and safely. Cisplatin (illustrated right) has been approved by the FDA as a treatment alone for bladder and ovarian cancer, and with other therapies for a…
-
Eli Lilly, Boehringer Ingelheim to Partner on Diabetes Drugs
Pharmaceutical manufacturers Eli Lilly and Company in Indianapolis and Boehringer Ingelheim in Germany have agreed to jointly develop and commercialize several of their diabetes compounds in mid- and late-stage development. The total value of the deal could reach $2.37 billion. The agreement covers Boehringer Ingelheim’s two oral diabetes agents — linagliptin and BI10773 — and…
-
National Lab, University Develop Tougher, Stronger Glass
A group of engineering and materials scientists have developed a new type of damage-tolerant metallic glass, demonstrating a strength and toughness that they say goes beyond that of any known material. The team had members from California Institute of Technology in Pasadena and the U.S. Department of Energy’s Lawrence Berkeley National Laboratory in Berkeley, California.…
-
Engineering Prof. Computes Available Biofuel Crop Lands
A detailed land analysis by researchers at University of Illinois in Champaign found that biofuel crops cultivated on available land could produce up to half of the world’s current fuel consumption, without affecting food crops or grazing land for livestock. Engineering professor Ximing Cai and two colleagues published their findings last month in the journal…
-
Consortium to Develop Sanfilippo B Gene Therapy
Amsterdam Molecular Therapeutics (AMT), a biopharmaceuticalcompany in the Netherlands, and a group of French research institutes, including the Institut Pasteur in Paris, has formed a consortium to develop a gene therapy to treat Sanfilippo B. AMT will manufacture compounds to be tested in a clinical trial of the therapy. Sanfilippo B is a rare genetic…
-
Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test
Opko Health Inc., a biotechnology company in Miami, Florida, said today it has a collaboration agreement with the drug manufacturer Bristol-Myers Squibb Company for Opko’s diagnostic test technology. Opko’s blood tests are being developed from its technology that identifies biomarkers for a range of diseases including neurodegenerative disorders. Part of the project calls for Opko…
-
Univ. Engineers Develop New Sewage Treatment Device
Research engineers at University of Utah in Salt Lake City have developed and commercialized an alternative device to help growing communities deal with sewage treatment. The device, known as Poo-Gloos because of their igloo-like shape (pictured right), supplement wastewater lagoons often used for sewage treatment, particularly in small, rural towns. Kraig Johnson and research colleagues…
-
Report: Nanotech Can Cut Green Energy Costs
In a new report, a technology research company estimates the use of available nanotechnologies can significantly reduce the cost of producing energy from renewable sources. ABI Research in New York says that worldwide investment in renewable energy will top $2 trillion on a cumulative basis from 2010 through 2015, but over that same period using…
-
Consumers Want, Will Pay for Predictive Health Tests
In a national survey conducted by researchers at Tufts Medical Center in Boston, Massachusetts, consumers indicated they place a high value on information to predict their future health, and may be willing to pay out of pocket to get it. The they survey was funded by the Institute for Health Technology Studies. The findings appear…
-
Myeloma Foundation Awards Biotech Research Grants
The Multiple Myeloma Research Foundation (MMRF) in Norwalk, Connecticut today announced awards of $1 million to each of three Massachusetts biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals Inc., Epizyme Inc., and Karyopharm Therapeutics Inc. Since the biotech program began in 2006, MMRF funded research at 11 companies leading to treatments for…